Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

被引:0
|
作者
Makiko Ono
Hitoshi Tsuda
Chikako Shimizu
Sohei Yamamoto
Tatsuhiro Shibata
Harukaze Yamamoto
Taizo Hirata
Kan Yonemori
Masashi Ando
Kenji Tamura
Noriyuki Katsumata
Takayuki Kinoshita
Yuichi Takiguchi
Hideki Tanzawa
Yasuhiro Fujiwara
机构
[1] National Cancer Center Hospital,Breast and Medical Oncology Division
[2] National Cancer Center Hospital,Clinical Laboratory Division, Department of Pathology
[3] National Defense Medical College,Department of Basic Pathology
[4] Center for Medical Genomics,Cancer Genomics Project, Pathology Division
[5] National Cancer,Breast Surgery Division
[6] Center Research Institute,Department of Respirology
[7] National Cancer Center Hospital,Department of Clinical Molecular Biology
[8] Graduate School of Medicine,undefined
[9] Chiba University,undefined
[10] Graduate School of Medicine,undefined
[11] Chiba University,undefined
来源
关键词
Triple-negative breast cancer; Neoadjuvant chemotherapy; Pathological complete response; Tumor-infiltrating lymphocytes; Tumor cell apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of the present study was to identify histological surrogate predictive markers of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC). Among 474 patients who received NAC and subsequent surgical therapy for stage II–III invasive breast carcinoma between 1999 and 2007, 102 (22%) had TNBC, and 92 core needle biopsy (CNB) specimens obtained before NAC were available. As controls, CNB specimens from 42 tumors of the hormone receptor-negative and HER2-positive (HR−/HER2+) subtype and 46 tumors of the hormone receptor-positive and HER2-negative (HR+/HER2−) subtype were also included. Histopathological examination including tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis, and immunohistochemical studies for basal markers were performed, and the correlation of these data with pathological therapeutic effect was analyzed. The rates of pCR at the primary site were higher for TNBC (32%) and the HR−/HER2+ subtype (21%) than for the HR+/HER2− subtype (7%) (P = 0.006). Expression of basal markers and p53, histological grade 3, high TIL scores, and apoptosis were more frequent in TNBC and the HR−/HER2+ subtype than in the HR+/HER2− subtype (P = 0.002 for TIL and P < 0.001 for others). In TNBC, the pCR rates of tumors showing a high TIL score and of those showing a high apoptosis score were 37 and 47%, respectively, and significantly higher or tended to be higher than those of the tumors showing a low TIL score and of the tumors showing a low apoptosis score (16 and 27%, respectively, P = 0.05 and 0.10). In a total of 180 breast cancers, the pCR rates of the tumors showing a high TIL score (34%) and of those showing a high apoptosis score (35%) were significantly higher than those of the tumors showing a low TIL score (10%) and those of the tumors showing a low apoptosis score (19%) (P = 0.0001 and 0.04, respectively). Histological grade and basal marker expression were not correlated with pCR. Although the whole analysis was exploratory, the degree of TIL correlated with immune response appear to play a substantial role in the response to NAC in TNBC.
引用
收藏
页码:793 / 805
页数:12
相关论文
共 50 条
  • [41] Tumor-infiltrating CD8+and FOXP3+lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy
    Miyashita, Minoru
    Sasano, Hironobu
    Tamaki, Kentaro
    Chan, Monica
    Hirakawa, Hisashi
    Suzuki, Akihiko
    Tada, Hiroshi
    Watanabe, Go
    Nemoto, Noriko
    Nakagawa, Saki
    Ishida, Takanori
    Ohuchi, Noriaki
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 525 - 534
  • [42] Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy
    Minoru Miyashita
    Hironobu Sasano
    Kentaro Tamaki
    Monica Chan
    Hisashi Hirakawa
    Akihiko Suzuki
    Hiroshi Tada
    Go Watanabe
    Noriko Nemoto
    Saki Nakagawa
    Takanori Ishida
    Noriaki Ohuchi
    [J]. Breast Cancer Research and Treatment, 2014, 148 : 525 - 534
  • [43] Artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC).
    Lee, Hee Jin
    Cho, Soo Yoon
    Cho, Eun Yoon
    Lim, Yoojoo
    Cho, Soo Ick
    Jung, Wonkyung
    Song, Sanghoon
    Kang, Mingu
    Ryu, Jeongun
    Ma, Minuk
    Park, Seonwook
    Paeng, Kyunghyun
    Ock, Chan-Young
    Song, Sang Yong
    Gong, Gyungyub
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancers (TNBC) treated with neoadjuvant chemotherapy (NAC)
    Herrero-Vicent, C.
    Guerrero, A.
    Gavila, J.
    Gozalbo, F.
    Blanch, S.
    Hernandez, A.
    Sandiego, S.
    Calatrava, A.
    Guillem, V.
    Ruiz, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [45] Tumor-infiltrating lymphocytes (TILs) is associated with improved overall survival in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NAC)
    Sampaio, Cd D. A. T.
    de Lima, V. C. C.
    de Andrade, V. P.
    Neotti, T.
    Tavares, M. C.
    Sessa, V. A.
    Calsavara, V. F.
    Zenun, G. R.
    Giongo, A. A.
    da Costa, A. A. B. A.
    [J]. CANCER RESEARCH, 2017, 77
  • [46] Predictive value of tumor-infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis
    Li, Xiaomin
    Tan, Qiuwen
    Li, Hongjiang
    Yang, Xiaoqin
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (01) : 89 - 95
  • [47] The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer
    Ilgun, Ahmet Serkan
    Aktepe, Fatma
    Gonullu, Onur
    Kapucuoglu, Nilgun
    Yararbas, Kanay
    Alco, Gul
    Ozturk, Alper
    Celebi, Filiz Elbuken
    Erdogan, Zeynep
    Ordu, Cetin
    Unal, Caglar
    Duymaz, Tomris
    Soybir, Gursel
    Yavuz, Ekrem
    Tuzlali, Sitki
    Ozmen, Vahit
    [J]. FUTURE ONCOLOGY, 2022, 18 (29) : 3289 - 3298
  • [48] Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer
    AiErken, NiJiati
    Shao, Nan
    Liu, Yuhong
    Shi, Huijuan
    Shi, Yawei
    Yuan, Zhongyu
    Lin, Ying
    [J]. BREAST CARE, 2023, 18 (05) : 390 - 398
  • [49] The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
    Ibrahim, Ezzeldin M.
    Al-Foheidi, Meteb E.
    Al-Mansour, Mubarak M.
    Kazkaz, Ghieth A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 467 - 476
  • [50] Correlation Between MRI and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
    Ku, You Jin
    Kim, Hak Hee
    Cha, Joo Hee
    Shin, Hee Jung
    Baek, Soo Heui
    Lee, Hee Jin
    Gong, Gyungyub
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (05) : 1146 - 1151